Related Experiment Video
Updated: Jul 8, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
The effect of donor against recipient one-way HLA mismatch on liver transplantation outcomes from a multicenter
Sunghae Park1, Young Rok Choi2, Dong Jin Joo3
1Department of Surgery, Samsung Medical Center, Sungkyunkwan University, School of Medicine, 50 Irwon-Dong, Gangnam-gu, Seoul, 135-710, Korea.
Abstract:
Donor against recipient one-way Human leukocyte antigen (HLA) mismatch (D → R one-way HLA MM) seemed strongly associated with graft-versus-host disease (GVHD). The aim of this study is to investigate the relevance of D → R one-way HLA MM in outcome of liver transplantation (LT). We retrospectively analyzed 2670 patients in Korean Organ Transplantation Registry database between April 2014 and December 2020. The patients were categorized into two groups whether D → R one-way HLA MM or not and evaluated the outcomes of LT between the two groups. 18 patients were found to be D → R one-way HLA MM. The incidence of GVHD (0.3% vs. 22.2%, p < 0.001) and mortality rate (11.6% vs. 38.9%, p = 0.003) was much higher in D → R one-way HLA MM group. D → R one-way HLA MM at 3 loci was seemed to be strongly associated with the incidence of GVHD (OR 163.3, p < 0.001), and found to be the strongest risk factor for patient death (HR 12.75, p < 0.001). Patients with D → R one-way HLA MM at 3 loci showed significantly lower overall survival (p < 0.001) but there were no significant differences in rejection-free survival and death-censored graft survival. D → R one-way HLA MM at 3 loci not only affects the overall survival of LT patients but also the incidence of GVHD.
Insights
Donor against recipient one-way Human Leukocyte Antigen (HLA) mismatch significantly increases graft-versus-host disease (GVHD) and mortality after liver transplantation (LT). This mismatch is a critical risk factor for patient death and impacts overall survival in LT recipients.
Area of Science:
- Transplantation Immunology
- Hepatology
Background:
- Donor against recipient one-way Human Leukocyte Antigen (HLA) mismatch (D→R one-way HLA MM) is associated with graft-versus-host disease (GVHD).
- The impact of D→R one-way HLA MM on liver transplantation (LT) outcomes requires further investigation.
Purpose of the Study:
- To investigate the clinical relevance of D→R one-way HLA MM in liver transplantation (LT).
- To evaluate the association between D→R one-way HLA MM and patient outcomes, including GVHD and mortality.
Main Methods:
- Retrospective analysis of 2670 patients undergoing LT between April 2014 and December 2020 from the Korean Organ Transplantation Registry database.
- Patients were categorized into groups based on the presence or absence of D→R one-way HLA MM.
- Outcomes including GVHD incidence, mortality rates, overall survival, rejection-free survival, and death-censored graft survival were compared between groups.
Main Results:
- Eighteen patients (0.67%) exhibited D→R one-way HLA MM.
- The D→R one-way HLA MM group showed significantly higher incidence of GVHD (22.2% vs. 0.3%) and mortality (38.9% vs. 11.6%).
- D→R one-way HLA MM at 3 loci was a strong risk factor for GVHD (OR 163.3) and patient death (HR 12.75), leading to significantly lower overall survival (p<0.001).
Conclusions:
- D→R one-way HLA MM at 3 loci is a significant risk factor impacting overall survival and GVHD incidence in liver transplant recipients.
- The presence of D→R one-way HLA MM negatively affects patient survival post-LT.
- No significant differences were observed in rejection-free survival and death-censored graft survival between groups.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cell-mediated Immune Responses

